129 related articles for article (PubMed ID: 31925772)
1. Molecular Bio-Imaging Probe for Non-Invasive Differentiation Between Human Leiomyoma Versus Leiomyosarcoma.
Shalaby S; Khater M; Laknaur A; Arbab A; Al-Hendy A
Reprod Sci; 2020 Feb; 27(2):644-654. PubMed ID: 31925772
[TBL] [Abstract][Full Text] [Related]
2. Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma.
Garcia N; Ulin M; Yang Q; Ali M; Bosland MC; Zeng W; Chen L; Al-Hendy A
Cells; 2023 Dec; 12(24):. PubMed ID: 38132150
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.
Adams CL; Dimitrova I; Post MD; Gibson L; Spillman MA; Behbakht K; Bradford AP
Exp Mol Pathol; 2019 Oct; 110():104284. PubMed ID: 31301306
[TBL] [Abstract][Full Text] [Related]
4. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging.
Sun S; Bonaffini PA; Nougaret S; Fournier L; Dohan A; Chong J; Smith J; Addley H; Reinhold C
Diagn Interv Imaging; 2019 Oct; 100(10):619-634. PubMed ID: 31427216
[TBL] [Abstract][Full Text] [Related]
5. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment?
DeMulder D; Ascher SM
AJR Am J Roentgenol; 2018 Dec; 211(6):1405-1415. PubMed ID: 30354268
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging features of uterine sarcoma and mimickers.
Barral M; Placé V; Dautry R; Bendavid S; Cornelis F; Foucher R; Guerrache Y; Soyer P
Abdom Radiol (NY); 2017 Jun; 42(6):1762-1772. PubMed ID: 28246921
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
8. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
[TBL] [Abstract][Full Text] [Related]
9. Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.
Lee JH; Ryu TY; Cho CH; Kim DK
Pathol Oncol Res; 2011 Jun; 17(2):201-5. PubMed ID: 20853077
[TBL] [Abstract][Full Text] [Related]
10. A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis.
Kim K; Kim S; Ahn T; Kim H; Shin SJ; Choi CH; Park S; Kim YB; No JH; Suh DH
BMC Cancer; 2023 Dec; 23(1):1215. PubMed ID: 38066476
[TBL] [Abstract][Full Text] [Related]
11. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing.
Mas A; Alonso R; Garrido-Gómez T; Escorcia P; Montero B; Jiménez-Almazán J; Martín J; Pellicer N; Monleón J; Simón C
Am J Obstet Gynecol; 2019 Oct; 221(4):320.e1-320.e23. PubMed ID: 31121144
[TBL] [Abstract][Full Text] [Related]
12. Development of Uterine Leiomyosarcoma During Follow-up After Caesarean Section in a Woman With Uterine Leiomyoma.
Watanabe K; Hayashi T; Katsumata M; Sano K; Abiko K; Konishi I
Anticancer Res; 2021 Jun; 41(6):3001-3010. PubMed ID: 34083291
[TBL] [Abstract][Full Text] [Related]
13. Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond.
Croce S; Chibon F
Genes Chromosomes Cancer; 2021 Mar; 60(3):129-137. PubMed ID: 33099852
[TBL] [Abstract][Full Text] [Related]
14. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application.
Sato S; Maekawa R; Yamagata Y; Tamura I; Lee L; Okada M; Jozaki K; Asada H; Tamura H; Sugino N
Sci Rep; 2016 Aug; 6():30652. PubMed ID: 27498619
[TBL] [Abstract][Full Text] [Related]
15. Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1228-1234. PubMed ID: 27564388
[TBL] [Abstract][Full Text] [Related]
16. [Benign metastatic leiomyoma of the corpus uteri].
Andreeva IuIu; Danilova NV; Shikeeva AA; Kekeeva TV; Zavalishina LE; Frank GA
Arkh Patol; 2012; 74(6):39-43. PubMed ID: 23383444
[TBL] [Abstract][Full Text] [Related]
17. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
Fletcher JA; Morton CC; Pavelka K; Lage JM
Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization.
Levy B; Mukherjee T; Hirschhorn K
Cancer Genet Cytogenet; 2000 Aug; 121(1):1-8. PubMed ID: 10958933
[TBL] [Abstract][Full Text] [Related]
19. Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.
Gao T; Finkelman BS; Ban Y; Li Y; Yin P; Bulun SE; Lu X; Ha C; Wei JJ
Cancer Sci; 2021 May; 112(5):2046-2059. PubMed ID: 33338329
[TBL] [Abstract][Full Text] [Related]
20. Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findings.
Aviram R; Ochshorn Y; Markovitch O; Fishman A; Cohen I; Altaras MM; Tepper R
J Clin Ultrasound; 2005 Jan; 33(1):10-3. PubMed ID: 15690441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
